AAAAAA

   
Results: 1-18 |
Results: 18
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
Authors: Stuart, MJ Chao, NS Horning, SJ Wong, RM Negrin, RS Johnston, LJ Shizuru, JA Long, GD Blume, KG Stockerl-Goldstein, KE Goldstein, S
Citation: Mj. Stuart et al., Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease, BIOL BLOOD, 7(10), 2001, pp. 552-560
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
Authors: Horning, SJ Negrin, RS Hoppe, RT Rosenberg, SA Chao, NJ Long, GD Brown, BW Blume, KG
Citation: Sj. Horning et al., High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial, BLOOD, 97(2), 2001, pp. 404-409
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma
Authors: Johnston, LJ Stockerl-Goldstein, KE Hu, WW Negrin, RS Hoppe, RT Blume, KG Horning, SJ
Citation: Lj. Johnston et al., Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma, BIOL BLOOD, 6(5A), 2000, pp. 555-562
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells
Authors: Stockerl-Goldstein, KE Reddy, SA Horning, SJ Blume, KG Chao, NJ Hu, WW Johnston, LJ Long, GD Strober, S Wong, RM Feiner, RH Kohler, S Negrin, RS
Citation: Ke. Stockerl-goldstein et al., Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells, BIOL BLOOD, 6(5), 2000, pp. 506-512
Autologous hematopoietic cell transplantation in Hodgkin's disease
Authors: Johnston, LJ Horning, SJ
Citation: Lj. Johnston et Sj. Horning, Autologous hematopoietic cell transplantation in Hodgkin's disease, BIOL BLOOD, 6(3A), 2000, pp. 289-300
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma
Authors: Alvarnas, JC Negrin, RS Horning, SJ Hu, WW Long, GD Schriber, JR Stockerl-Goldstein, K Tierney, K Wong, R Blume, KG Chao, NJ
Citation: Jc. Alvarnas et al., High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma, BIOL BLOOD, 6(3A), 2000, pp. 352-358
Advances in the treatment of Hodgkin's lymphoma
Authors: Horwitz, SM Horning, SJ
Citation: Sm. Horwitz et Sj. Horning, Advances in the treatment of Hodgkin's lymphoma, CURR OPIN H, 7(4), 2000, pp. 235-240
Response criteria for NHL: Importance of 'normal' lymph node size and correlations with response rates
Authors: Grillo-Lopez, AJ Cheson, BD Horning, SJ Peterson, BA Carter, WD Varns, CL Klippenstein, DL Shen, CD
Citation: Aj. Grillo-lopez et al., Response criteria for NHL: Importance of 'normal' lymph node size and correlations with response rates, ANN ONCOL, 11(4), 2000, pp. 399-408
Follicular lymphoma: Have we made any progress?
Authors: Horning, SJ
Citation: Sj. Horning, Follicular lymphoma: Have we made any progress?, ANN ONCOL, 11, 2000, pp. 23-27
Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492
Authors: Horning, SJ Wiliams, J Bartlett, NL Bennett, JM Hoppe, RT Neuberg, D Cassileth, P
Citation: Sj. Horning et al., Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492, J CL ONCOL, 18(5), 2000, pp. 972-980
Introduction - Monoclonal antibody therapy for hematologic malignancies: Prospects for an integrated therapy approach
Authors: Horning, SJ
Citation: Sj. Horning, Introduction - Monoclonal antibody therapy for hematologic malignancies: Prospects for an integrated therapy approach, SEM HEMATOL, 37(4), 2000, pp. 1-1
Investigation of monoclonal antibody therapy with conventional and high-dose treatment: Current clinical trials
Authors: Horning, SJ
Citation: Sj. Horning, Investigation of monoclonal antibody therapy with conventional and high-dose treatment: Current clinical trials, SEM HEMATOL, 37(4), 2000, pp. 27-33
Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma
Authors: Johnston, LJ Horning, SJ
Citation: Lj. Johnston et Sj. Horning, Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma, HEMAT ONCOL, 13(5), 1999, pp. 889
Gemcitabine is active in relapsed Hodgkin's disease
Authors: Lucas, JB Horwitz, SM Horning, SJ Sayegh, A
Citation: Jb. Lucas et al., Gemcitabine is active in relapsed Hodgkin's disease, J CL ONCOL, 17(8), 1999, pp. 2627-2628
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
Authors: Cheson, BD Horning, SJ Coiffier, B Shipp, MA Fisher, RI Connors, JM Lister, TA Vose, J Grillo-Lopez, A Hagenbeek, A Cabanillas, F Klippensten, D Hiddemann, W Castellino, R Harris, NL Armitage, JO Carter, W Hoppe, R Canellos, GP
Citation: Bd. Cheson et al., Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas, J CL ONCOL, 17(4), 1999, pp. 1244-1253
Treatment of early-stage Hodgkin's disease
Authors: Advani, RH Horning, SJ
Citation: Rh. Advani et Sj. Horning, Treatment of early-stage Hodgkin's disease, SEM HEMATOL, 36(3), 1999, pp. 270-281
Treatment of stage III-IV Hodgkin's disease
Authors: Horning, SJ Yahalom, J Tesch, H Fisher, RI Raemaekers, JMM
Citation: Sj. Horning et al., Treatment of stage III-IV Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 483-506
Primary refractory Hodgkin's disease
Authors: Horning, SJ
Citation: Sj. Horning, Primary refractory Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 97-101
Risultati: 1-18 |